Start with your question. Search first, choose the closest subject and keep personal details private. Posting guidelines
Notifications
Clear all
Topic starter
21/08/2022 5:15 pm
Bloodwork question about PT-141. Baseline, a year in, and the numbers moved in a direction I did not expect.
I would rather have a narrow conclusion and be right than a broad one and be interesting.
What the peptide class does pharmacologically does not require the subjective effect to be large to be real.
Where does the human data stop and the extrapolation start?